HopeStage
Back to all studies
RecruitingNCT07634809

Eye movement and body signals during ADHD medication in children

About this titleRead the official source — NCT07634809
Observational studyAges 6–17Sweden
The study in practice

Understand this study

Who could participate?

This study is for people with ADHD. Listed age limits: 6 years to 17 years. Other eligibility criteria apply.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 10, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
150
Sponsor
Umeå University
Sponsor type
University
Study type
Observational
Intervention type
Drug
Locations
Sweden
Age range
From 6 Years to 17 Years
Official registry ID
NCT07634809
Official title
Show the full official title

Evaluation of the Relationship Between Medication, Eye Movements, and Autonomic Nervous System Functions in Children and Adolescents With ADHD

Recruitment & locations

Currently recruiting

Umeå

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Umeå University, a university.

Does this study involve medication?

Yes. The study involves medication, including metylphenidate.

Who can participate?

This study is for people with ADHD. Listed age limits: 6 years to 17 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies